Standout Papers

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease s... 2000 2026 2008 2017 588
  1. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis (2000)
    Timothy M. Cox, Robin Lachmann et al. The Lancet

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
15 intermediate papers

Works of Chris Moyses being referenced

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus
1999
Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM
1997
and 3 more

Author Peers

Author Last Decade Papers Cites
Chris Moyses 684 312 235 385 12 1.0k
Hers Hg 573 529 157 215 20 1.4k
Claudia Blasetti Fantauzzi 305 414 208 88 17 1.2k
Idit Ron 599 325 59 120 30 970
Heather Hughes 535 347 35 134 8 869
J S Zhu 352 501 161 101 8 914
Marc C. Daniels 232 919 209 243 21 1.3k
Chonglun Xie 505 570 98 141 14 1.2k
B. J. H. M. Poorthuis 429 340 35 80 30 906
Genaro Hernandez 170 825 49 116 19 1.3k
Dorothy L. Fillerup 326 388 48 96 14 904

All Works

Loading papers...

Rankless by CCL
2026